The early impact of carbohydrate restriction was clinically significant but not sustained, according to authors of a new meta-analysis.
Timing appears to be nearly everything when it comes to the impact of respiratory infection on autoantibody seroconversion in infants at risk for tpye 1 diabetes.
You can attempt to renegotiate. Sometimes it works . . . but sometimes it doesn’t.
The extended-release GLP-1 agonist was added to usual care in T2DM patients with and without previous cardiac disease.
At-a-Glance: Studies you may find of interest look at AFib in T1DM, new fracture risk data, obesity outcomes, and more.
In a new study, an intensive lifestyle intervention did not markedly decrease A1c but had significant impact on need for medication.
A new meta-analysis finds that routine intake of artificial sweeteners is linked to the opposite of the intended effect.
Here: 3 strategies that can help fuel the patient's drive to change.
A successful lifestyle intervention for advanced diabetes and improved access to diabetic eye care for rural patients showcase telemedicine at its best.
What's new in research on bisphosphonates, body-fat measurement, prebiotics, and insulin dosing? Find out with our quiz.
Slide Show: Highlights of new research on online diabetes games, benefits of alcohol, and predictors of T2DM remission.
A roundup of the latest research on osteoporotic fracture risk, bariatric surgery outcomes, and effects of sleep on BMI.
Results of a small systematic review identify a vulnerable ethnic group members of which may be patients in your practice.
Mindfulness: a potential intervention for T2DM?
Was this pharmacist out of bounds? You make the call.